Clinical Trials Directory

Trials / Completed

CompletedNCT04647539

Emerging Invasive Fungal Infections in Critically Ill Patients

Emerging Invasive Fungal Infections in Critically Ill Patients: Epidemiological Trends, Clinical Features and Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Rationale: Beside Candida and Aspergillus, emerging invasive fungal infections (EIFIs) are increasing in intensive care setting and are associated with high morbidity and mortality. However, data are scarce, particularly in ICU settings and for EIFIs other than mucormycosis. Objectives: to describe epidemiological trends and clinical features of EIFIs in intensive care units (ICU) and to assess their outcome. Methods: All records of adult patients diagnosed with an EIFI in a medical ICU between 2006 and 2019 were analyzed retrospectively. In-ICU mortality was assessed, then factors associated with mortality were identified. Survival at day-90 was calculated by the Kaplan-Meier method.

Conditions

Timeline

Start date
2006-01-01
Primary completion
2019-12-01
Completion
2020-11-23
First posted
2020-12-01
Last updated
2020-12-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04647539. Inclusion in this directory is not an endorsement.